Douglas Tsao
Stock Analyst at H.C. Wainwright
Total Price Targets
26
Stocks Covered
17
Sectors
Healthcare
Most Recent
Mar 4, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Douglas Tsao
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | $10.00 | $9.71 | +3.0% | 2 | Mar 4, 2026 |
| ROIV | Roivant Sciences Ltd. | $34.00 | $28.06 | +21.2% | 2 | Mar 4, 2026 |
| ALKS | Alkermes plc | $43.00 | $33.49 | +28.4% | 3 | Feb 26, 2026 |
| RZLT | Rezolute, Inc. | $5.00 | $3.31 | +51.3% | 2 | Dec 12, 2025 |
| RAPP | Rapport Therapeutics, Inc. Common Stock | $40.00 | $34.13 | +17.2% | 1 | Dec 9, 2025 |
| ARQT | Arcutis Biotherapeutics, Inc. | $30.00 | $23.37 | +28.4% | 2 | Oct 29, 2025 |
| VRDN | Viridian Therapeutics, Inc. | $34.00 | $13.41 | +153.5% | 2 | Oct 21, 2025 |
| OTLK | Outlook Therapeutics, Inc. | $1.00 | $0.27 | +275.9% | 1 | Aug 29, 2025 |
| APLS | Apellis Pharmaceuticals, Inc. | $57.00 | $40.95 | +39.2% | 2 | Nov 6, 2024 |
| EOLS | Evolus, Inc. | $27.00 | $5.29 | +410.9% | 1 | Oct 3, 2024 |
| XENE | Xenon Pharmaceuticals Inc. | $53.00 | $56.81 | -6.7% | 1 | Oct 1, 2024 |
| IRON | Disc Medicine, Inc. | $70.00 | $67.31 | +4.0% | 1 | Sep 16, 2024 |
| PTGX | Protagonist Therapeutics, Inc. | $50.00 | $98.16 | -49.1% | 2 | Sep 12, 2024 |
| IMVT | Immunovant, Inc. | $51.00 | $27.11 | +88.1% | 1 | Sep 10, 2024 |
| PRAX | Praxis Precision Medicines, Inc. | $60.30 | $330.59 | -81.8% | 1 | Sep 4, 2024 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $69.00 | $38.93 | +77.2% | 1 | Aug 9, 2024 |
| TBPH | Theravance Biopharma, Inc. | $15.00 | $16.76 | -10.5% | 1 | Aug 6, 2024 |
Recent Activity
- Mar 4, 2026— Set$34.00price target onROIV(Roivant Sciences Ltd.)
- Mar 4, 2026— Set$10.00price target onBHVN(Biohaven Ltd.)
- Feb 26, 2026— Set$43.00price target onALKS(Alkermes plc)
- Dec 12, 2025— Set$5.00price target onRZLT(Rezolute, Inc.)
- Dec 9, 2025— Set$40.00price target onRAPP(Rapport Therapeutics, Inc. Common Stock)
- Oct 29, 2025— Set$30.00price target onARQT(Arcutis Biotherapeutics, Inc.)
- Oct 21, 2025— Set$34.00price target onVRDN(Viridian Therapeutics, Inc.)
- Sep 9, 2025— Set$46.00price target onALKS(Alkermes plc)
- Aug 29, 2025— Set$1.00price target onOTLK(Outlook Therapeutics, Inc.)
- Dec 30, 2024— Set$19.00price target onARQT(Arcutis Biotherapeutics, Inc.)
- Nov 6, 2024— Set$57.00price target onAPLS(Apellis Pharmaceuticals, Inc.)
- Oct 14, 2024— Set$37.00price target onALKS(Alkermes plc)
- Oct 3, 2024— Set$27.00price target onEOLS(Evolus, Inc.)
- Oct 1, 2024— Set$53.00price target onXENE(Xenon Pharmaceuticals Inc.)
- Sep 24, 2024— Set$59.00price target onBHVN(Biohaven Ltd.)
- Sep 16, 2024— Set$70.00price target onIRON(Disc Medicine, Inc.)
- Sep 12, 2024— Set$50.00price target onPTGX(Protagonist Therapeutics, Inc.)
- Sep 10, 2024— Set$51.00price target onIMVT(Immunovant, Inc.)
- Sep 10, 2024— Set$7.00price target onRZLT(Rezolute, Inc.)
- Sep 4, 2024— Set$60.30price target onPRAX(Praxis Precision Medicines, Inc.)
Frequently Asked Questions
Who is Douglas Tsao?
Douglas Tsao is a stock analyst at H.C. Wainwright covering 17 stocks primarily in Healthcare. They have issued 26 price targets since Apr 3, 2024.
What stocks does Douglas Tsao cover?
Douglas Tsao currently covers 17 stocks, including ALKS, BHVN, ROIV, RZLT, ARQT.
What is Douglas Tsao's latest price target?
Douglas Tsao's most recent price target was $34.00 on ROIV (Roivant Sciences Ltd.), set on Mar 4, 2026.
What is Douglas Tsao's highest price target?
Douglas Tsao's highest issued price target is $83.00 on APLS, set on Aug 2, 2024.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.